top of page
Search
Samso News: Vitrafy Life Sciences — IMV Strategic Commercial Agreement Marks a Commercial Validation Step - A Definite #SamsoDYOR and a strong consideration for position play.
Vitrafy Life Sciences Limited (ASX: VFY) released a market update on 15 January 2026 outlining a strategic commercial agreement with global animal reproduction leader IMV Technologies. The agreement positions Vitrafy’s cryopreservation technology within IMV’s global product and distribution platform, marking a material step in Vitrafy’s commercial execution strategy following Samso’s earlier IPO coverage of the Company.
Noel Ong
Jan 287 min read
Vitrafy Life Sciences Limited (ASX: VFY) — Turning Cryopreservation Innovation into Market Reality - Animal and Human Health Solutions.
Vitrafy Life Sciences Limited (ASX: VFY) is a Melbourne-based life sciences company offering a fully integrated cryopreservation solution via its proprietary hardware and cloud-based software platform, LifeChain™. Listed on the ASX on 6 November 2024, Vitrafy has been swift in translating its IPO capital into tangible milestones in both technological development and early commercial traction.
Noel Ong
Jun 25, 20258 min read
bottom of page